Viveve Announces Topline Results from Pivotal U.S. VIVEVE II Trial for Improvement of Sexual Function in Women Apr 9, 2020
Viveve Announces Completion of VIVEVE II Pivotal FDA Clinical Trial for Improvement of Sexual Function Mar 12, 2020
Viveve to Host Conference Call to Provide Corporate Update and Year-End 2019 Financial Results on March 19, 2020 Mar 6, 2020
Viveve Completes Enrollment in Short-Term Feasibility Study for Stress Urinary Incontinence Mar 4, 2020
Viveve Initiates Enrollment of its Short-Term Feasibility Study in Stress Urinary Incontinence Jan 14, 2020
Viveve Announces Authorization to Initiate Short-Term Feasibility Study in Stress Urinary Incontinence from Canadian Ministry of Health Dec 18, 2019
